<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220426054664N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-05-31</date_registration>
      <primary_sponsor>Ahvaz University of Medical Sciences</primary_sponsor>
      <public_title>Coldceramic in primary Tooth Pulpotomy</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation and comparison of the effectiveness of mineral trioxide aggregate and cold ceramic in the success of primary molars pulpotomy: a clinical and radiographic study</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-06-10</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>42</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/63389</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: N/A, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Blinding description: Participants enter the study with their consent but do not know each tooth  with which material  was pulpotomized.
The clinical caregiver treats primary pulpotomy but is unaware of the type and purpose of the study.
Evaluators evaluate the clinical outcome and radiographs of treated teeth. They know the purpose of the study , but they do not know the type of material used for each pulpotomy treatment and group assignment.
The person responsible for collecting the data is also unaware of the type of intervention and the type of substance used to treat the pulpotomy and to assign groups.
Data analysts are aware of the type of intervention and group allocation.</study_design>
      <phase>4</phase>
      <hc_freetext>pulpotomy.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Treatment of primary molar pulpotomy with cold ceramic , which is made in Iran and contains compounds of calcium oxide, silicon acid, these compounds are 93% of its components. Other components include MgO, MnO, Fe2O3, Na2O, K2O and TiO2. (First, anesthesia is performed in a child who is eligible for the study, and then tooth decay is removed and accessed, and cervical molar pulpotomy is performed and placed on wet cotton pulp for five minutes for homeostasis, then wet cotton. It is removed and the cold-ceramic powder is mixed with sterile serum in a ratio of 1: 1. When the paste is formed, it is placed on a pulp that has already been homeostasized, and glass ionomer light is placed on it and cured for 40 seconds, and finally the metal is coated. It is used as a permanent repair. Intervention 2: Control group:  Treatment of primary molar pulpotomy with mineral trioxide aggregate, Made in Iran and contains compounds of tricalcium silicate, dicalcium silicate, tricalcium aluminate, tetracalcium aluminophyte, calcium sulfate and bismuth oxide. (First, anesthesia is performed in a child who is eligible for the study, and then tooth decay is removed and accessed, and cervical molar pulpotomy is performed and placed on wet cotton pulp for five minutes for homeostasis, then wet cotton. It is removed and the mineral trioxide aggregate powder is mixed with sterile serum in a ratio of 1: 1. When the paste is formed, it is placed on a pulp that has already been homeostasized, and glass ionomer light is placed on it and cured for 40 seconds, and finally the metal is coated. It is used as a permanent repair.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Evaluation and Comparison of Mineral Trioxide Aggregate and coldceramic in Primary Tooth Pulpotomy: Clinical and Radiographic Study

When:
Start the access period at the same time as printing the results

To whom:
for everyone

Conditions:
کو

Where to obtain:
bitarasteh992@gmail.com

How to obtain:
Send the request via email and receive a response within a month

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Bita Rasteh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No.14, damavand 7 building, Esfahan, Dey street</address>
        <city>Ahwaz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6381944814</zip>
        <telephone>+98 61 4352 4848</telephone>
        <email>bitarasteh99@gmail.com</email>
        <affiliation>Ahvaz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Bita Rasteh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No.14, damavand 7 building, Esfahan, Dey street</address>
        <city>Ahvaz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>63819448114</zip>
        <telephone>+98 61 4352 4848</telephone>
        <email>bitarasteh@gmail.com</email>
        <affiliation>Ahvaz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>General and mental health of the child
Lack of clinical adverse symptoms in the target tooth such as spontaneous pain or nocturnal pain, swelling of pulpal origin, pathological sagging, fistula
Lack of adverse radiographic signs of the desired tooth such as internal root resorption, external root resorption and periapical or furca area</inclusion_criteria>
      <agemin>4 years</agemin>
      <agemax>9 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Failure to refer the patient for 3 and 6 month follow-up
Having an underlying disease</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Treatment of primary molar pulpotomy with cold ceramic , which is made in Iran and contains compounds of calcium oxide, silicon acid, these compounds are 93% of its components. Other components include MgO, MnO, Fe2O3, Na2O, K2O and TiO2. (First, anesthesia is performed in a child who is eligible for the study, and then tooth decay is removed and accessed, and cervical molar pulpotomy is performed and placed on wet cotton pulp for five minutes for homeostasis, then wet cotton. It is removed and the cold-ceramic powder is mixed with sterile serum in a ratio of 1: 1. When the paste is formed, it is placed on a pulp that has already been homeostasized, and glass ionomer light is placed on it and cured for 40 seconds, and finally the metal is coated. It is used as a permanent repair</i_keyword>
      <i_keyword>Control group:  Treatment of primary molar pulpotomy with mineral trioxide aggregate, Made in Iran and contains compounds of tricalcium silicate, dicalcium silicate, tricalcium aluminate, tetracalcium aluminophyte, calcium sulfate and bismuth oxide. (First, anesthesia is performed in a child who is eligible for the study, and then tooth decay is removed and accessed, and cervical molar pulpotomy is performed and placed on wet cotton pulp for five minutes for homeostasis, then wet cotton. It is removed and the mineral trioxide aggregate powder is mixed with sterile serum in a ratio of 1: 1. When the paste is formed, it is placed on a pulp that has already been homeostasized, and glass ionomer light is placed on it and cured for 40 seconds, and finally the metal is coated. It is used as a permanent repair.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Success of pulpotomy treatment. Timepoint: Follow-up 3 and 6 months after treatment. Method of measurement: Radiographs and clinical examination.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Ahvaz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-01-01</approval_date>
        <contact_name>Ethics committee of Ahwaz University of Medical Sciences</contact_name>
        <contact_address>No:14، Damavand7 building، Esfahan، Dey Street Ahwaz Khouzestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
